Deep Science Ventures (DSV) is a London-based venture creator and incubator founded in 2016 by Dominic Falcão and Mark Hammond. The company focuses on combining scientific knowledge with entrepreneurial talent to develop high-impact ventures that address major global challenges, particularly in climate tech and sustainability. DSV emphasizes technical expertise and urgency in solving pressing problems, supporting ambitious founders with deep technical backgrounds.
DSV operates in five key sectors: agriculture, computation, climate, pharma, and education. It has launched 56 companies, with 37 currently in development, and has achieved a portfolio valuation of approximately $500 million. The ventures have made significant contributions, including removing 260 kg of CO2, restoring 300 hectares of sustainable land, and developing 24 drugs. DSV provides up to 18 months of funding and access to specialized teams, allowing founders to work on pre-scoped opportunities and potentially form multiple companies.
With offices in London, New York, Amsterdam, and Zurich, DSV partners with industry leaders and investors to de-risk ventures and enhance their impact, aiming to create a sustainable future for humanity and the planet.
Deep Science Ventures (DSV) is a London-based venture creator and incubator founded in 2016 by Dominic Falcão and Mark Hammond. The company focuses on combining scientific knowledge with entrepreneurial talent to develop high-impact ventures that address major global challenges, particularly in climate tech and sustainability. DSV emphasizes technical expertise and urgency in solving pressing problems, supporting ambitious founders with deep technical backgrounds.
DSV operates in five key sectors: agriculture, computation, climate, pharma, and education. It has launched 56 companies, with 37 currently in development, and has achieved a portfolio valuation of approximately $500 million. The ventures have made significant contributions, including removing 260 kg of CO2, restoring 300 hectares of sustainable land, and developing 24 drugs. DSV provides up to 18 months of funding and access to specialized teams, allowing founders to work on pre-scoped opportunities and potentially form multiple companies.
With offices in London, New York, Amsterdam, and Zurich, DSV partners with industry leaders and investors to de-risk ventures and enhance their impact, aiming to create a sustainable future for humanity and the planet.
